계명대학교 의학도서관 Repository

The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.1)

Metadata Downloads
Author(s)
Min-Sung KimSe-Il GoChan Woo WeeMin Ho LeeSeok-Gu KangKyeong-O GoSae Min KwonWoohyun KimYun-Sik DhoSung-Hye ParkYoungbeom SeoSang Woo SongStephen AhnHyuk-Jin OhHong In YoonSea-Won LeeJoo Ho LeeKyung Rae ChoJung Won ChoiJe Beom HongKihwan HwangChul-Kee ParkDo Hoon Lim
Keimyung Author(s)
Kwon, Sae Min
Department
Dept. of Neurosurgery (신경외과학)
Journal Title
Brain Tumor Res Treat
Issued Date
2023
Volume
11
Issue
2
Keyword
Brain tumorsCrisisDelphiGuidelineKorean Society for Neuro-Oncology
Abstract
Background:
During the coronavirus disease 2019 (COVID-19) pandemic, the need for appropriate treatment guidelines for patients with brain tumors was indispensable due to the lack and limitations of medical resources. Thus, the Korean Society for Neuro-Oncology (KSNO), a multidisciplinary academic society, has undertaken efforts to develop a guideline that is tailored to the domestic situation and that can be used in similar crisis situations in the future.

Methods:
The KSNO Guideline Working Group was composed of 22 multidisciplinary experts on neuro-oncology in Korea. In order to reach consensus among the experts, the Delphi method was used to build up the final recommendations.

Results:
All participating experts completed the series of surveys, and the results of final survey were used to draft the current consensus recommendations. Priority levels of surgery and radiotherapy during crises were proposed using appropriate time window-based criteria for management outcome. The highest priority for surgery is assigned to patients who are life-threatening or have a risk of significant impact on a patient's prognosis unless immediate intervention is given within 24-48 hours. As for the radiotherapy, patients who are at risk of compromising their overall survival or neurological status within 4-6 weeks are assigned to the highest priority. Curative-intent chemotherapy has the highest priority, followed by neoadjuvant/adjuvant and palliative chemotherapy during a crisis period. Telemedicine should be actively considered as a management tool for brain tumor patients during the mass infection crises such as the COVID-19 pandemic.

Conclusion:
It is crucial that adequate medical care for patients with brain tumors is maintained and provided, even during times of crisis. This guideline will serve as a valuable resource, assisting in the delivery of treatment to brain tumor patients in the event of any future crisis.
Keimyung Author(s)(Kor)
권세민
Publisher
School of Medicine (의과대학)
Type
Article
ISSN
2288-2413
Source
https://btrt.org/DOIx.php?id=10.14791/btrt.2023.0009
DOI
10.14791/btrt.2023.0009
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/44955
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.